Bruker Corporation (BRKR) to Issue Quarterly Dividend of $0.05 on October 7th

Bruker Corporation (NASDAQ:BRKR) announced a quarterly dividend on Friday, August 14th. Investors of record on Monday, September 21st will be paid a dividend of 0.05 per share by the medical research company on Wednesday, October 7th. This represents a c) dividend on an annualized basis and a dividend yield of 0.3%. The ex-dividend date is Monday, September 21st.

Bruker has increased its dividend payment by an average of 0.0%per year over the last three years. Bruker has a dividend payout ratio of 7.3% indicating that its dividend is sufficiently covered by earnings. Analysts expect Bruker to earn $2.43 per share next year, which means the company should continue to be able to cover its $0.20 annual dividend with an expected future payout ratio of 8.2%.

Bruker Trading Down 2.6%

Shares of NASDAQ:BRKR traded down $1.66 on Friday, hitting $61.39. 2,820,290 shares of the company’s stock were exchanged, compared to its average volume of 2,108,620. The stock has a market capitalization of $9.35 billion, a price-to-earnings ratio of -87.70, a price-to-earnings-growth ratio of 1.93 and a beta of 1.26. The company has a debt-to-equity ratio of 0.76, a current ratio of 1.85 and a quick ratio of 0.92. Bruker has a 12 month low of $30.09 and a 12 month high of $65.30. The business’s 50 day simple moving average is $58.17 and its two-hundred day simple moving average is $49.90.

Bruker (NASDAQ:BRKR) last issued its earnings results on Tuesday, August 4th. The medical research company reported $0.49 EPS for the quarter, topping analysts’ consensus estimates of $0.38 by $0.11. Bruker had a negative net margin of 2.35% and a positive return on equity of 12.47%. The business had revenue of $838.50 million for the quarter, compared to analyst estimates of $853.57 million. During the same period last year, the company posted $0.32 earnings per share. The company’s quarterly revenue was up 5.2% compared to the same quarter last year. Bruker has set its FY 2026 guidance at 2.100-2.150 EPS. Analysts anticipate that Bruker will post 2.12 EPS for the current fiscal year.

About Bruker

Bruker Corporation develops and manufactures scientific instruments, analytical systems and software used to study the chemical, physical and biological properties of materials. Its customers include universities, pharmaceutical and biotechnology companies, industrial manufacturers, hospitals, government laboratories and other research organizations.

The company’s product portfolio includes nuclear magnetic resonance and electron paramagnetic resonance systems, mass spectrometers, X-ray analysis instruments, optical and molecular spectroscopy systems, microscopy and nanoanalysis tools, and instruments for microbiology and spatial biology.